Document is current
Any future updates will be listed below
-
Authors
Hou, Wenpin http://orcid.org/0000-0003-0972-2192
Ji, Zhicheng
Chen, Zeyu
Wherry, E. John
Hicks, Stephanie C. http://orcid.org/0000-0002-7858-0231
Ji, Hongkai http://orcid.org/0000-0002-6480-0141
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG010889)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG009518)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (K99HG011468)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R00HG011468)
National Institute of Health
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R00HG009007)
Silicon Valley Community Foundation (Advised Fund)
Chan Zuckerberg Initiative DAF
- License Information
-
More Information
Article History
Received: 11 July 2021
Accepted: 24 October 2023
First Online: 10 November 2023
Competing interests
: E.J.W. is a member of the Parker Institute for Cancer Immunotherapy that supports research in the Wherry lab. E.J.W. is an advisor for Danger Bio, Marengo, Janssen, NewLimit, Pluto Immunotherapeutics Related Sciences, Santa Ana Bio, and Synthekine. E.J.W. is a founder of and holds stock in Arsenal Biosciences and holds stock in Coherus. Other authors declare no competing interests.
